Resistance to checkpoint blockade therapy through inactivation of antigen presentation.
Nature Communications
Sade-Feldman, Moshe M; Jiao, Yunxin J YJ; Chen, Jonathan H JH; Rooney, Michael S MS; Barzily-Rokni, Michal M; Eliane, Jean-Pierre JP; Bjorgaard, Stacey L SL; Hammond, Marc R MR; Vitzthum, Hans H; Blackmon, Shauna M SM; Frederick, Dennie T DT; Hazar-Rethinam, Mehlika M; Nadres, Brandon A BA; Van Seventer, Emily E EE; Shukla, Sachet A SA; Yizhak, Keren K; Ray, John P JP; Rosebrock, Daniel D; Livitz, Dimitri D; Adalsteinsson, Viktor V; Getz, Gad G; Duncan, Lyn M LM; Li, Bo B; Corcoran, Ryan B RB; Lawrence, Donald P DP; Stemmer-Rachamimov, Anat A; Boland, Genevieve M GM; Landau, Dan A DA; Flaherty, Keith T KT; Sullivan, Ryan J RJ; Hacohen, Nir N